PONTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.878
EU - Europa 7.082
AS - Asia 2.182
SA - Sud America 40
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 9
OC - Oceania 7
Totale 25.211
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.588
GB - Regno Unito 2.829
IT - Italia 1.562
SE - Svezia 812
CN - Cina 753
DE - Germania 619
SG - Singapore 591
UA - Ucraina 433
HK - Hong Kong 336
TR - Turchia 305
FI - Finlandia 248
CA - Canada 220
BG - Bulgaria 163
FR - Francia 161
MX - Messico 67
RU - Federazione Russa 50
VN - Vietnam 46
ID - Indonesia 38
IN - India 37
IE - Irlanda 33
NL - Olanda 32
BE - Belgio 24
BR - Brasile 22
LT - Lituania 21
JP - Giappone 19
MY - Malesia 16
ES - Italia 13
RO - Romania 13
CH - Svizzera 12
KR - Corea 11
CZ - Repubblica Ceca 10
EU - Europa 10
IR - Iran 9
CL - Cile 8
LU - Lussemburgo 8
PT - Portogallo 7
AU - Australia 6
NO - Norvegia 6
PE - Perù 5
PL - Polonia 5
AT - Austria 4
DK - Danimarca 4
LB - Libano 4
NG - Nigeria 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
SI - Slovenia 3
AR - Argentina 2
HU - Ungheria 2
IL - Israele 2
MD - Moldavia 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
SD - Sudan 2
TH - Thailandia 2
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SM - San Marino 1
VE - Venezuela 1
Totale 25.211
Salva come PNG Salva come JPEG
Città #
Fairfield 2.538
Southend 2.473
Woodbridge 1.578
Ashburn 1.233
Houston 1.155
Seattle 975
Chandler 923
Jacksonville 828
Cambridge 809
Wilmington 809
Dearborn 786
Santa Clara 746
Ann Arbor 661
Nyköping 543
Singapore 436
Hong Kong 331
Modena 275
Beijing 264
San Diego 206
Princeton 203
Ottawa 192
Izmir 188
Sofia 163
Eugene 155
Helsinki 114
Bremen 81
London 79
Milan 79
New York 78
Rome 77
Redwood City 54
Grafing 51
Dong Ket 44
Jakarta 37
Shanghai 37
Des Moines 34
Norwalk 34
Frankfurt am Main 33
Fremont 33
Boardman 31
Dublin 30
Guangzhou 25
Bologna 23
Hefei 23
Nanjing 22
San Mateo 21
Dongguan 20
Hounslow 19
Kilburn 18
Buffalo 17
Falls Church 17
Kunming 17
Turin 17
Chiswick 16
Palermo 16
Parma 16
Brussels 15
Phoenix 15
Munich 14
Tulare 14
Cagliari 13
Toronto 13
Padova 12
Dallas 11
Genova 11
Jinan 11
Saint Petersburg 11
Verona 11
Auburn Hills 10
Augusta 10
Mumbai 10
Naples 10
Napoli 10
Wuhan 10
Bari 9
Pescara 9
Brno 8
Genoa 8
Indiana 8
Salerno 8
Segrate 8
Waanrode 8
Amsterdam 7
Chieti 7
Florence 7
Fuzhou 7
Los Angeles 7
Nanchang 7
Ansbach 6
Castelnuovo Rangone 6
Catania 6
Ceranova 6
Leawood 6
Mountain View 6
Reggio Emilia 6
Trieste 6
Zhengzhou 6
Atlanta 5
Bergamo 5
Brescia 5
Totale 20.071
Salva come PNG Salva come JPEG
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 453
Neoplasie maligne e benigne associate al melanoma multiplo: coinvolgimento di MITF, PTEN and CDKN2A nella cancerogenesi melanocitaria multipla. 444
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome. 275
The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients 273
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor 262
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 258
Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker 254
BRAF ,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival 248
Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome 248
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology 245
Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report 240
"Collision" metastasis from unknown primary squamous cell carcinoma and papillary microcarcinoma of thyroid presenting as lateral cervical cystic mass 236
Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes. 235
PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS) 232
Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria 230
Grey-blue regression in melanoma in situ-evaluation on 111 cases. 225
Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients 224
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 223
Hypomelanosis of Ito with a trisomy 2 mosaicism: a case report 222
Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome 222
Confocal microscopy characterization of BRAFV600E mutated melanomas 221
Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanomas 218
Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: Sphenoid asymmetry in a patient with a novel PTCH1 mutation 216
Reticular grey-blue areas of regression as a dermoscopic marker of melanoma in situ. 215
Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy 215
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 213
Congenital Glioblastoma multiforme and eruptive disseminated Spitz nevi 211
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 211
Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome. 209
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 207
Fibroepithelioma of Pinkus: Solitary tumor or sign of a complex gastrointestinal syndrome 204
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 204
Seminal cell free DNA concentration levels discriminate between prostate cancer and benign prostatic hyperplasia 204
A novel CYLD germline mutation in Brooke-Spiegler syndrome. 203
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. 203
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 203
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 203
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 203
Aetiology of colorectal cancer and relevance of monogenic inheritance. 202
Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors. 202
Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics. 201
Desmoplastic melanoma: a challenge for the oncologist 201
High Magnification Digital Dermoscopy of Basal Cell Carcinoma: A Single-centre Study on 400 cases. 199
Mismatch Repair Gene Deficiency and Genetic Anticipation in Lynch Syndrome 199
Role of microsatellite instability, immunohistochemistry and Mismatch Repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre Syndrome. 196
Dermoscopy of small melanomas: just a miniaturized dermoscopy? 195
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 195
Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors? 195
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 195
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 193
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 193
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 193
Wall paintings facies and their possible genetic correlates in the ancient Pompeii: A bio-anthropologic message from the past? 189
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. 189
Microsatellite instability and colorectal cancer prognosis. 188
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma 188
Biomarkers associated with COVID-19 disease progression 188
Stem cell properties in cell cultures from different stage of melanoma progression. 187
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 184
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 183
Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients 182
Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies 181
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 180
Seminal cell-free DNA assessment as a novel prostate cancer biomarker 180
Clinical utility gene card for: Gorlin syndrome - update 2013. 178
Skeletal stigmata as keys to access to the composite and ancient Gorlin-Goltz syndrome history: The Egypt, Pompeii and Herculaneum lessons 177
The dermoscopic variability of pigment network in melanoma in situ. 175
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations. 175
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 171
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 168
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 168
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 166
Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers 165
High-resolution imaging of basal cell carcinoma: a comparison between multiphoton microscopy with fluorescence lifetime imaging and reflectance confocal microscopy. 165
Variegated Dermoscopy of in situ Melanoma. 164
Giuseppe Moscati (1880-1927): a holistic approach to medicine 164
Microsatellite instability, immunohistochemistry and germline mismatch repair gene mutations for the diagnosis of Muir-Torre syndrome in immunosuppressed patients 164
Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study on 140 cases. 163
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 163
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 162
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 162
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report 161
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 160
Proteomic Analysis of PTCH1+/- Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients. 160
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 159
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. 158
Diagnosis of BCC by multiphoton laser tomography. 155
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 155
High resolution diagnosis of common nevi by multiphoton laser tomography and fluorescence lifetime imaging. 154
Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics 154
Distinctive clinical and dermoscopic features of BRAFp.V600K mutated melanomas. 151
Quantitative evaluation of healthy epidermis by means of multiphoton microscopy and fluorescence lifetime imaging microscopy 151
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 150
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 149
The impact of histopathologic diagnosis on the proper management of testis neoplasms. 144
Muir-Torre Syndrome and founder Mismatch Repair genes mutations: A long gone historical genetic challenge 142
Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications 142
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 141
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 141
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer 140
Totale 19.707
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.022 0 0 0 0 660 894 1.039 816 809 217 403 184
2020/20215.065 608 167 482 421 656 347 428 567 224 537 289 339
2021/20223.306 260 412 347 182 73 176 175 184 360 238 553 346
2022/20232.776 357 345 210 236 329 383 59 255 316 51 133 102
2023/20241.862 86 90 129 174 383 193 193 216 53 48 100 197
2024/20251.560 193 63 92 405 807 0 0 0 0 0 0 0
Totale 25.613